Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive italian study tracks 96,000 MS patients to unlock better care

NCT ID NCT07636876

First seen Jun 09, 2026 · Last updated Jun 17, 2026 · Updated 3 times

Summary

This study is creating a large database of up to 96,000 people in Italy with multiple sclerosis (MS) and similar conditions like neuromyelitis optica. Researchers will collect health information over time to understand the diseases better, improve treatment, and guide healthcare decisions. Participants are not given any new treatments; they simply allow their medical data to be used for research.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Fondazione Italiana Sclerosi Multipla (FISM ETS)

    Genova, Genova, 16149, Italy

Conditions

The condition(s) this trial relates to.

autoimmune disease demyelinating disease demyelinating disease of central nervous system multiple sclerosis myelin oligodendrocyte glycoprotein antibody-associated disease neuromyelitis optica

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.